News

Under the agreement, ProBioGen will integrate some of Boehringer’s technologies to accommodate a seamless process and technology transfer from pilot and medium-scale to commercial-scale production capacities. ProBioGen’s clients

The company has enrolled the first cohort (100mg) in a Phase I clinical trial that will evaluate the safety and pharmacokinetics of up to four single ascending doses

Under the terms of the agreement, Roche grants a non-exclusive worldwide license to Biotecon authorizing them to develop, produce, and sell kits in the food and GMO (genetically

The AZ-007 Phase I clinical trial enrolled 40 healthy volunteers at a single US clinical center. The purpose of this trial was to assess the safety, tolerability and

The LipiScan device uses near-infrared spectroscopy to identify lipid core containing plaques of interest in the coronary arteries in patients already undergoing cardiac catheterization. Such plaques, which cannot

The primary endpoint of the study was the proportion of patients who achieved either a Major Clinical Response (MCR) or Partial Clinical Response (PCR) using the Bilag instrument

Under this agreement, Scil Technology is primarily responsible for all R&D activities with Medtronic responsible for clinical trials, regulatory approvals and commercialization. These regenerative biologics may offer new

The laboratory-cultured models of human skin, called EST-1000 and AST-2000 were developed by CellSystems and contain cells manufactured by Lifeline. These three-dimensional skin cell models are used as

Unisom SleepMelts, which contains 25mg of diphenhydramine hydrochloride, was developed by Eurand using its AdvaTab and Microcaps taste-masking technologies. The product was developed as part of the EUR-1047